Enanta Pharmaceuticals
ENTA
ENTA
111 hedge funds and large institutions have $220M invested in Enanta Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 39 increasing their positions, 31 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
4.31% less ownership
Funds ownership: 104.49% → 100.19% (-4.3%)
23% less capital invested
Capital invested by funds: $287M → $220M (-$67.1M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
111
Holding in Top 10
1
Calls
$54K
Puts
$49K
Top Buyers
| 1 | +$3.09M | |
| 2 | +$2.56M | |
| 3 | +$2.15M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$1.18M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$903K |
Top Sellers
| 1 | -$7.46M | |
| 2 | -$3.66M | |
| 3 | -$3.46M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$3.2M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$2.93M |